Human Papillomavirus Genotype Replacement: Still Too Early to Tell?

Although postvaccination surveillance thus far is reassuring, it is still too early to preclude type replacement. Monitoring of NVTs remains pivotal in gauging population-level impacts of HPV vaccination.